Trial result ·
Effects of progestin-primed ovarian stimulation protocol plus clomiphene citrate in patients with low basal LH levels: a randomized controlled trial.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This trial looked at people with infertility and low LH levels. People were put into groups by chance. It ran from 2018 to 2021 and took in 230 people. In one group, 115 people got hMG, MPA and clomiphene citrate. The other 115 people got hMG and MPA only. The main goal was to compare the egg collection rate.
What they found
Clomiphene citrate helped the body release more LH. Even so, the group given it had a lower egg collection rate. This group also ended up with fewer frozen embryos. The number of eggs collected was similar in both groups. The share of eggs that could be used was also similar. Rates of pregnancy and live birth did not differ clearly between groups.
What it means for patients
The authors say clomiphene citrate raised LH in these people. But adding it to this plan led to a lower egg collection rate. They say doctors should use this drug mix with care here. The trial did not show a clear gain in births from adding it.
Why it is not certain yet
The results only apply to people with low LH levels. Gaps in pregnancy and birth rates were not clear enough to be sure. The abstract does not say if people knew which group they were in. It also does not give details on side effects. A single trial can only tell so much.
Source
Effects of progestin-primed ovarian stimulation protocol plus clomiphene citrate in patients with low basal LH levels: a randomized controlled trial.
PubMed · PMID 42978013We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Female infertility publications